ArticleCureus2025
ZAP-X Stereotactic Radiosurgery for Optic Nerve Sheath Meningioma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stereotactic radiosurgery using a self-shielded gyroscopic radiosurgery system for meningiomas: technical aspects and dosimetric results.Radiation oncology (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary optic nerve sheath meningiomas (ONSMs) are benign tumors and are a common cause of optic neuropathy due to compression of the optic nerve. Management of this tumor can be surgery or radiotherapy, but radiotherapy is the preferred treatment modality due to the risk of damage to the vasculature and resulting vision loss in surgery. The ZAP-X (ZAP Surgical Systems, Inc., San Carlos, CA) is currently the newest cranial stereotactic radiosurgery (SRS) platform. There are no reports describing its use or outcomes for ONSM. We present the case of the first documented patient to undergo ZAP-X SRS for the treatment of a primary ONSM. The patient was a 68-year-old woman with a 0.27 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.